Senti Biosciences Inc (SNTI)
0.3972
+0.02
(+4.53%)
USD |
NASDAQ |
May 17, 16:00
0.38
-0.02
(-4.33%)
After-Hours: 20:00
Senti Biosciences Total Liabilities (Quarterly): 46.09M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 46.09M |
| December 31, 2023 | 52.57M |
| September 30, 2023 | 48.83M |
| June 30, 2023 | 46.21M |
| March 31, 2023 | 49.08M |
| Date | Value |
|---|---|
| December 31, 2022 | 53.53M |
| September 30, 2022 | 49.10M |
| June 30, 2022 | 48.10M |
| December 31, 2021 | 208.16M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
46.09M
Minimum
Mar 2024
208.16M
Maximum
Dec 2021
66.85M
Average
49.08M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 102.18M |
| Shareholders Equity (Quarterly) | 56.09M |